Ongoing research continues to improve our understanding of BRCA1 and BRCA2 mutations and their role in cancer. New developments in gene editing technologies, such as CRISPR, hold promise for future therapies that could correct these mutations. Additionally, advancements in personalized medicine are leading to more tailored prevention and treatment strategies for individuals with BRCA mutations.
